Results of a federally-funded pooled analysis of five prospective cohort studies proved that cigarette smoking prior to the first diagnosis of lung in stage I, bladder, kidney or head and neck cancer can enhance risk of developing a second smoking-associated cancer. And this is the largest study to date discovering risk of second cancers among all those smokers at the present.
An analysis of five large, prospective cohort studies indicates that lung (stage I), bladder, kidney and head and neck cancer survivors who smoked 20 or more cigarettes a day prior to their cancer diagnoses have an up to five-fold higher risk of developing a second smoking-associated cancer compared to survivors of the same cancers who never smoked.
The association between smoking and developing a second primary smoking-associated cancer was similar to the association between smoking and developing a first primary smoking-associated cancer (patients who smoked more than 20 cigarettes per day had a 5.41-fold higher risk of developing cancer than individuals who have never smoked).
Notably, current smoking at any level increased the risk of overall mortality across all cancer disease sites. The study, published on November 10 in the Journal of Clinical Oncology, affirms the 2014 Surgeon General reports conclusion that patients and survivors who smoke are at a higher risk of developing a second cancer.
Clinicians term an individuals initial diagnosis a first primary cancer. A second primary cancer is one diagnosed at some point after the first diagnosis. Second primary cancers are not metastases of the first cancer but instead are distinct, new malignancies. This study focused on patients with a history of cancer who developed a second primary cancer.
As survival improves for a number of smoking-related cancers, patients are living longer; however, smoking may increase the risk of developing a second smoking-related cancer among these survivors, said lead study author Meredith S. Shiels, PhD, MHs, a research fellow with the National Cancer Institutes Division of Cancer Epidemiology and Genetics. Our study demonstrates that health care providers should emphasize the importance of smoking cessation to all their patients, including cancer survivors.
Tobacco use constitutes the largest preventable cause of death and disability in developed countries and is a rapidly growing health problem in developing nations. It is responsible for 30% of all cancer deaths and is associated with increased risk for at least 17 types of cancer. However, few studies have explored the association between smoking and second cancer risk. According to the authors, this is the largest study of its kind.
Researchers examined data from five prospective epidemiologic cohorts, which included 2,552 patients with stage I lung, 6,386 with bladder, 3,179 with kidney and 2,967 with head and neck cancer from the following studies:
National Institutes of Health-AARP Diet and Health Study
Agricultural Health Study
Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
Iowa Womens Health Study
Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
A total of 866 second primary smoking-associated cancers were diagnosed among the survivors. The association between smoking status prior to primary cancer diagnosis and second smoking-associated cancer risk was assessed. Across all four cancer types, survivors who smoked 20 or more cigarettes per day at prior to their first primary diagnoses were more likely to develop a second smoking-associated cancer when compared to those who never smoked.
Specifically, the risk increases were as follows:
Stage I Lung Cancer: 3.3 times more likely to develop a second cancer
Bladder Cancer: 3.7 times more likely to develop a second cancer
Head and Neck Cancers: 4.5 times more likely to develop a second cancer
Kidney Cancer: 5.3 times more likely to develop a second cancer
Current smokers who smoked fewer than 20 cigarettes per day and former smokers who had quit before their first cancer diagnosis also had an elevated risk of developing a second primary smoking-associated cancer compared to survivors who never smoked (although risks decreased with the number of years since smoking cessation).
Dr. Shiels stated that further examination and research should directly assess the association between smoking after a first cancer diagnosis and smoking after second cancer risk. This research was supported in part by the Intramural Research Program of the National Cancer Institute and also National Institutes of Health to get accurate results.